Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alkermes (ALKS) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Alkermes (ALKS) over the last 16 years, with Q3 2025 value amounting to $307000.0.

  • Alkermes' Gains from Investment Securities rose 477.82% to $307000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $31.1 million, marking a year-over-year decrease of 182.09%. This contributed to the annual value of $29.6 million for FY2024, which is 408.44% up from last year.
  • As of Q3 2025, Alkermes' Gains from Investment Securities stood at $307000.0, which was up 477.82% from $1.7 million recorded in Q2 2025.
  • In the past 5 years, Alkermes' Gains from Investment Securities registered a high of $28.8 million during Q1 2025, and its lowest value of $293000.0 during Q3 2024.
  • For the 5-year period, Alkermes' Gains from Investment Securities averaged around $6.6 million, with its median value being $1.7 million (2025).
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first soared by 302553.19% in 2021, then crashed by 8975.49% in 2022.
  • Quarter analysis of 5 years shows Alkermes' Gains from Investment Securities stood at $2.9 million in 2021, then tumbled by 89.75% to $301000.0 in 2022, then soared by 695.35% to $2.4 million in 2023, then plummeted by 85.63% to $344000.0 in 2024, then fell by 10.76% to $307000.0 in 2025.
  • Its last three reported values are $307000.0 in Q3 2025, $1.7 million for Q2 2025, and $28.8 million during Q1 2025.